bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2024.11.18.624092

Hypometabolism in Autism Spectrum Disorder: Insights from Brain and Blood Transcriptomics

Balasubramanian, R.·Saha, D.·Arun, A.·Vinod, P. K.
View original source ↗Export metadata ↓

Abstract

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by challenges in social communication, repetitive behaviors, and restricted interests. Recent research has emphasized the importance of metabolic dysfunctions in the pathophysiology of ASD. This study investigates metabolic alterations associated with ASD by analyzing transcriptomic data obtained from the prefrontal cortex (bulk tissue and single-nucleus) and data from peripheral blood mononuclear cells (PBMC). We assessed the metabolic activity of each patient based on gene expression profiles, revealing significant downregulation of vital metabolic pathways, including glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation, indicative of hypometabolism. Our analysis also highlighted dysregulation in lipid, vitamin, amino acid, and heme metabolism, which may contribute to the neurodevelopmental delays associated with ASD. Cell-specific metabolic activities in the ASD brain showed altered pathways in astrocytes, oligodendrocytes, excitatory neurons, and interneurons. Furthermore, we identified critical metabolic pathways and genes from PBMC gene expression data that distinguish ASD patients from typically developing individuals. Our findings demonstrate a consistent pattern of metabolic dysfunction across brain and blood samples. This research provides a comprehensive understanding of metabolic alterations in ASD, paving the way for exploring potential therapeutic strategies targeting metabolic dysregulation.

Source connections

Explore related subjects

systems biologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Balasubramanian, R., Saha, D., Arun, A., Vinod, P. K.. 2024-11-19. Hypometabolism in Autism Spectrum Disorder: Insights from Brain and Blood Transcriptomics. https://doi.org/10.1101/2024.11.18.624092

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Mapping a genome-scale in vivo knockout screen to a mechanistic network model identifies VAV2, RASA1, and LEPR as regulators of cardiomyocyte hypertrophy

Cardiomyocyte hypertrophy is a leading clinical predictor of heart failure, yet newly identified candidate genes often remain disconnected from the signaling mechanisms that govern cardiomyocyte growth. We developed a computational-experimental pipeline that integrates genome-scale mouse knockout phenotypes with a logic-based differential equation model of hypertrophic signaling. Among 9,605 genes evaluated by the International Mouse Phenotyping Consortium, 939 knockout lines induced abnormal heart morphology. Directional curation of hypertrophy-related sub-phenotypes followed by interaction-based network expansion mapped 37 genes to the signaling model. Virtual knockdown screening identified five candidates with concordant in vivo and in silico effects: LRIG1 and CBL as predicted negative regulators and VAV2, RASA1, and LEPR as predicted positive regulators. Mechanistic subnetwork analysis linked these candidates to distinct receptor-proximal, Ras, PI3K-AKT, and MAPK signaling axes. In neonatal rat cardiomyocytes, siRNA-mediated depletion of VAV2, RASA1, or LEPR reduced phenylephrine-induced cell growth, supporting their cell-autonomous contribution to hypertrophy. Quantitative phenotyping further validated the predicted decreased cardiac hypertrophy for VAV2 and LEPR knockouts but identified potential age-dependent mechanisms for RASA1 knockout. Overall, this study establishes the application of network models to translate from in vivo phenotypic screens into pathway mechanisms.

systems biology↗
bioRxiv2026

SpaReg: sparsity-based 3D reconstruction of tissue microenvironments at native resolution across morphological and spatial molecular modalities

Tissue microenvironments comprise cellular and acellular components whose three-dimensional (3D) architecture guides disease fate. Direct imaging of intact specimens by light-sheet and multiphoton microscopy, and computational reconstruction from serial sections, have established that 3D spatial context reveals cell and tissue organization inaccessible at single planes. Computational reconstruction in particular can leverage archived human tissue, benefiting from the cost-effectiveness, robustness, scalable storage, workflow compatibility, and century-long pathobiology knowledge of histology, and can integrate multiple spatial modalities. However, sectioning can introduce tears and folds, and computational alignment can further distort tissue integrity. Here we introduce SpaReg, a sparsity-based 3D reconstruction method spanning histology, spatial proteomics and spatial transcriptomics. Across multiple organs, SpaReg robustly reconstructs large tissue volumes with preserved subcellular morphology despite sectioning artifacts. On a standardized histology benchmark, SpaReg achieves the best balance between 3D reconstruction accuracy and tissue integrity, and on spatial transcriptomics benchmarks it ranks among the leading methods while scaling to hundreds of sections and millions of cells in a dataset that several existing methods fail to process. Preservation of subcellular morphology by SpaReg also enables training of a Hematoxylin and Eosin (H&E)-based epithelial, T and B cell classifier, generating single-cell-resolved 3D maps directly from H&E. Applied to pancreatic tissue containing pancreatic ductal adenocarcinoma arising from an intraductal papillary mucinous neoplasm, these maps reveal that 2D sections overestimate immune exclusion, and resolve lymphoid aggregates in 3D. SpaReg, therefore, provides a scalable foundation for morphologically faithful, multimodal 3D atlases and spatially informed disease modeling

systems biology↗
bioRxiv2026

TxCyto: A machine learning framework for estimating cytokine activity from whole transcriptome

Cytokines are critical mediators of intercellular communication, and a comprehensive characterization of their activity is essential for understanding health and disease. Existing tools to infer cytokine activity rely on experimental measurements. However, such measurements are available only for a small minority (43) of cytokines, and moreover, cytokine activity and response are highly context-specific, making a comprehensive experimental profiling across tissues, disease states, and biological contexts impractical. To address this gap, we developed TxCyto - a deep learning-based framework that infers the activity of cytokines, and more broadly of the tumor secretome, directly from the whole transcriptome profile of a sample. Trained on pan-cancer TCGA tumor transcriptomes, TxCyto was extensively validated in multiple independent datasets, including cytokine perturbation experiments. Across multiple cancer immunotherapy cohorts, TxCyto identified cytokines whose predicted activity was associated with therapeutic response. Furthermore, in spatial transcriptomic data for Liver cancer, TxCyto discovered spatial niches associated with response to immunotherapy. Overall, we develop a machine learning tool -TxCyto, for predicting the activity of 645 cytokines and tumor secretome from readily available whole transcriptomes. The TxCyto framework is generally applicable to other classes of regulatory molecules and TxCyto code base, and the tools are provided at https://github.com/Rahulncbs/TxCyto.

systems biology↗